GLATIRAMER

GLATIRAMER was reported 59611 times

GLATIRAMER is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ELSBERG SYNDROME 5 0.3846
1 HAEMORRHAGIC ADRENAL INFARCTION 6 0.3750
2 FALLOPIAN TUBE NEOPLASM 2 0.0952
3 AUTONOMIC DYSREFLEXIA 15 0.0926
4 CORRECTED TRANSPOSITION OF GREAT VESSELS 2 0.0909
5 WRONG DEVICE USED 40 0.0610
6 CLINICALLY ISOLATED SYNDROME 5 0.0526
7 BORDERLINE OVARIAN TUMOUR 3 0.0448
8 MUCOCUTANEOUS LEISHMANIASIS 5 0.0410
9 PROGRESSIVE RELAPSING MULTIPLE SCLEROSIS 5 0.0403
10 RELAPSING MULTIPLE SCLEROSIS 12 0.0397
11 EMBOLIA CUTIS MEDICAMENTOSA 28 0.0352
12 TOXIC NEUROPATHY 13 0.0330
13 RELAPSING-REMITTING MULTIPLE SCLEROSIS 28 0.0324
14 MENINGITIS STAPHYLOCOCCAL 4 0.0282
15 AMNIORRHEXIS 2 0.0278
16 PATERNAL EXPOSURE BEFORE PREGNANCY 8 0.0263
17 HERPES SIMPLEX REACTIVATION 10 0.0262
18 ADMINISTRATION SITE INDURATION 2 0.0222
19 EXPANDED DISABILITY STATUS SCALE SCORE INCREASED 24 0.0192
20 CSF CULTURE POSITIVE 2 0.0189
21 ABORTION 51 0.0175
22 TACHYCARDIA PAROXYSMAL 5 0.0172
23 ADMINISTRATION SITE PRURITUS 2 0.0155
24 CSF OLIGOCLONAL BAND PRESENT 2 0.0154
25 HERPES ZOSTER REACTIVATION 4 0.0153
26 MULTIPLE SCLEROSIS PSEUDO RELAPSE 5 0.0147
27 PLEUROTHOTONUS 13 0.0144
28 ADMINISTRATION SITE IRRITATION 2 0.0143
29 INJECTED LIMB MOBILITY DECREASED 2 0.0140
30 LACK OF INJECTION SITE ROTATION 24 0.0137
31 OVARIAN FAILURE 7 0.0131
32 IMMEDIATE POST-INJECTION REACTION 14 0.0127
33 HIGH RISK PREGNANCY 5 0.0123
34 INJECTION SITE NECROSIS 24 0.0118
35 ENCEPHALITIS BRAIN STEM 2 0.0116
36 URTICARIAL VASCULITIS 6 0.0114
37 ENCEPHALOMYELITIS 3 0.0110
38 MULTIPLE SCLEROSIS 522 0.0109
39 BRAIN SCAN ABNORMAL 6 0.0108
40 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 20 0.0106
41 LEISHMANIASIS 3 0.0103
42 LIPOATROPHY 9 0.0095
43 JC VIRUS INFECTION 15 0.0094
44 MAGNETIC RESONANCE IMAGING ABNORMAL 11 0.0092
45 CAUDA EQUINA SYNDROME 7 0.0091
46 HISTAMINE INTOLERANCE 2 0.0088
47 PULMONARY NECROSIS 3 0.0088
48 PREMATURE MENOPAUSE 8 0.0087
49 LOCAL REACTION 6 0.0081
50 OESOPHAGEAL ATRESIA 5 0.0080
51 INJECTION RELATED REACTION 13 0.0079
52 INJECTION SITE INDENTATION 17 0.0078
53 INJECTION SITE ATROPHY 12 0.0073
54 ENTEROCOLITIS BACTERIAL 2 0.0072
55 MUSCLE STRENGTH ABNORMAL 3 0.0072
56 ADMINISTRATION SITE ERYTHEMA 2 0.0070
57 ANAL SPHINCTER ATONY 3 0.0070
58 MULTIPLE SCLEROSIS RELAPSE 476 0.0069
59 EOSINOPHILIC PLEURAL EFFUSION 2 0.0067
60 WEST NILE VIRAL INFECTION 5 0.0067
61 NEEDLE FATIGUE 3 0.0066
62 LACK OF ADMINISTRATION SITE ROTATION 2 0.0066
63 NECROTISING RETINITIS 4 0.0063
64 DEVELOPMENTAL HIP DYSPLASIA 5 0.0060
65 JC POLYOMAVIRUS TEST POSITIVE 7 0.0060
66 INJECTION SITE PUSTULE 2 0.0052
67 DRUG ADMINISTERED IN WRONG DEVICE 5 0.0051
68 INJECTION SITE MASS 189 0.0051
69 INJECTION SITE INDURATION 65 0.0050
70 LIPODYSTROPHY ACQUIRED 10 0.0047
71 MYELITIS 7 0.0045
72 PARAPARESIS 8 0.0045
73 ATRIOVENTRICULAR SEPTAL DEFECT 2 0.0043
74 PROTHROMBIN LEVEL DECREASED 4 0.0043
75 PAPILLOMA VIRAL INFECTION 7 0.0042
76 INJECTION SITE SCAR 12 0.0042
77 ESCHAR 3 0.0041
78 BRAIN STEM SYNDROME 3 0.0040
79 CERVICAL INCOMPETENCE 2 0.0039
80 BLADDER DYSFUNCTION 4 0.0039
81 LIMB MALFORMATION 3 0.0038
82 MOLLUSCUM CONTAGIOSUM 2 0.0037
83 PROGRESSIVE MULTIPLE SCLEROSIS 4 0.0035
84 HYPERAMMONAEMIC ENCEPHALOPATHY 6 0.0034
85 HYPERBILIRUBINAEMIA NEONATAL 2 0.0034
86 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 28 0.0034
87 DYSMETRIA 2 0.0033
88 OPTIC NEURITIS 30 0.0033
89 INFECTIOUS PLEURAL EFFUSION 5 0.0033
90 TUNNEL VISION 6 0.0032
91 OPHTHALMOPLEGIA 5 0.0032
92 CEREBELLAR ATAXIA 3 0.0031
93 QUADRIPARESIS 5 0.0030
94 VACCINATION FAILURE 5 0.0030
95 ACUTE PROMYELOCYTIC LEUKAEMIA 3 0.0029
96 INJECTION SITE OEDEMA 5 0.0029
97 INJECTION SITE URTICARIA 71 0.0029
98 TEETH BRITTLE 3 0.0029
99 WALKING DISABILITY 6 0.0029
100 MONOCYTE PERCENTAGE INCREASED 2 0.0028
101 MONOPARESIS 5 0.0028
102 EXPIRED DEVICE USED 9 0.0027
103 INJECTION SITE CELLULITIS 5 0.0027
104 PERONEAL NERVE PALSY 15 0.0026
105 INJECTION SITE REACTION 177 0.0026
106 CROUP INFECTIOUS 2 0.0025
107 TRIGEMINAL NEURALGIA 10 0.0025
108 INJECTION SITE PRURITUS 164 0.0024
109 HYPERTONIC BLADDER 7 0.0024
110 INJECTION SITE SWELLING 185 0.0024
111 NEUROGENIC BLADDER 5 0.0024
112 BAND SENSATION 3 0.0024
113 GLIOBLASTOMA 4 0.0023
114 INJECTION SITE DISCOLOURATION 29 0.0023
115 AXONAL NEUROPATHY 2 0.0023
116 INTESTINAL PSEUDO-OBSTRUCTION 2 0.0023
117 AREFLEXIA 6 0.0022
118 MATERNAL EXPOSURE DURING BREAST FEEDING 9 0.0022
119 MUSCLE NECROSIS 2 0.0022
120 DEVICE MECHANICAL ISSUE 30 0.0022
121 BONE CONTUSION 2 0.0022
122 CENTRAL NERVOUS SYSTEM LYMPHOMA 3 0.0022
123 HAEMANGIOMA 5 0.0022
124 INJECTION SITE ULCER 2 0.0021
125 LYMPHOPENIA 30 0.0021
126 BLADDER TRANSITIONAL CELL CARCINOMA 3 0.0021
127 PARAPLEGIA 6 0.0021
128 CARDIAC ANEURYSM 2 0.0020
129 MYELOFIBROSIS 6 0.0020
130 INJECTION SITE VESICLES 12 0.0020
131 AUTONOMIC NEUROPATHY 2 0.0020
132 GENITAL HERPES 3 0.0020
133 PRODUCT SUBSTITUTION ISSUE 112 0.0019
134 VARICELLA ZOSTER VIRUS INFECTION 4 0.0019
135 INJECTION SITE ERYTHEMA 239 0.0019
136 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
137 INJECTION SITE WARMTH 39 0.0019
138 BURNS THIRD DEGREE 2 0.0019
139 CENTRAL NERVOUS SYSTEM LESION 26 0.0019
140 DEVICE USE ISSUE 33 0.0019
141 OPTIC ATROPHY 3 0.0018
142 INJECTION SITE IRRITATION 23 0.0018
143 OLIGOHYDRAMNIOS 6 0.0018
144 ELECTRIC SHOCK SENSATION 5 0.0018
145 CORNEAL OEDEMA 4 0.0018
146 LYMPHOCYTE COUNT ABNORMAL 2 0.0018
147 URINARY TRACT DISORDER 8 0.0018
148 MOANING 2 0.0018
149 IMMUNE THROMBOCYTOPENIA 8 0.0017
150 ADMINISTRATION SITE PAIN 2 0.0017
151 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 4 0.0017
152 CORONAVIRUS INFECTION 11 0.0017
153 NORMAL NEWBORN 9 0.0017
154 MATERNAL EXPOSURE DURING PREGNANCY 147 0.0016
155 FEBRILE CONVULSION 2 0.0016
156 CEREBROSPINAL FLUID LEAKAGE 3 0.0016
157 OPPORTUNISTIC INFECTION 3 0.0016
158 INJECTION SITE INFLAMMATION 8 0.0016
159 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 8 0.0016
160 INJECTION SITE HYPERSENSITIVITY 5 0.0016
161 HEPATIC NECROSIS 6 0.0016
162 FRACTURED COCCYX 2 0.0016
163 GESTATIONAL HYPERTENSION 2 0.0015
164 INJECTION SITE NODULE 17 0.0015
165 FEAR OF INJECTION 11 0.0015
166 HEMIPARESIS 26 0.0015
167 INJECTION SITE INFECTION 5 0.0015
168 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 2 0.0015
169 ARTHRITIS INFECTIVE 7 0.0015
170 ANXIETY DISORDER 5 0.0015
171 CYSTITIS NONINFECTIVE 2 0.0015
172 INJECTION SITE DISCHARGE 8 0.0015
173 CLUMSINESS 4 0.0015
174 MENINGITIS VIRAL 2 0.0015
175 THERAPY INTERRUPTED 104 0.0015
176 HEAD TITUBATION 2 0.0015
177 INCISIONAL HERNIA 2 0.0014
178 SERUM SICKNESS 4 0.0014
179 INJECTION SITE DISCOMFORT 15 0.0014
180 MAST CELL ACTIVATION SYNDROME 2 0.0014
181 SLEEP DEFICIT 3 0.0014
182 INJECTION SITE HYPOAESTHESIA 2 0.0014
183 NEEDLE ISSUE 40 0.0014
184 INJECTION SITE PAIN 421 0.0014
185 INJECTION SITE BRUISING 109 0.0014
186 APRAXIA 2 0.0013
187 SKIN NECROSIS 7 0.0013
188 ATAXIA 16 0.0013
189 INJECTION SITE PARAESTHESIA 2 0.0013
190 MUSCLE SPASTICITY 16 0.0013
191 FLUSHING 132 0.0013
192 BACTERIAL VAGINOSIS 2 0.0013
193 HEPATITIS E 2 0.0013
194 IDIOPATHIC THROMBOCYTOPENIC PURPURA 2 0.0013
195 INTESTINAL OPERATION 2 0.0013
196 HISTOPLASMOSIS DISSEMINATED 2 0.0013
197 VARICELLA 3 0.0013
198 EXPOSURE VIA BREAST MILK 5 0.0013
199 PRODUCT LEAKAGE 7 0.0012
200 INTRACRANIAL ANEURYSM 5 0.0012
201 PREMATURE RUPTURE OF MEMBRANES 3 0.0012
202 GUILLAIN-BARRE SYNDROME 6 0.0012
203 PANNICULITIS 3 0.0012
204 HYPOGLYCAEMIA NEONATAL 2 0.0012
205 CARDIOVASCULAR INSUFFICIENCY 2 0.0012
206 ACUTE PSYCHOSIS 3 0.0012
207 BLOOD IMMUNOGLOBULIN G DECREASED 3 0.0012
208 THERAPY CESSATION 62 0.0012
209 INJECTION SITE ABSCESS 3 0.0012
210 MENOPAUSE 3 0.0012
211 CONCUSSION 9 0.0012
212 ACUTE SINUSITIS 2 0.0012
213 HEPATIC LESION 5 0.0012
214 IMMUNOSUPPRESSION 10 0.0011
215 GASTROINTESTINAL STROMAL TUMOUR 3 0.0011
216 PHARYNGEAL SWELLING 11 0.0011
217 BLADDER DISORDER 11 0.0011
218 INVASIVE DUCTAL BREAST CARCINOMA 3 0.0011
219 INJECTION SITE PAPULE 5 0.0011
220 HEPATITIS ACUTE 7 0.0011
221 BLADDER SPASM 2 0.0011
222 ADENOCARCINOMA OF COLON 2 0.0011
223 ABORTION INDUCED 10 0.0011
224 WALKING AID USER 7 0.0011
225 NARCOLEPSY 2 0.0011
226 VOMITING PROJECTILE 3 0.0010
227 ABDOMINAL WALL HAEMATOMA 2 0.0010
228 LYMPHOPROLIFERATIVE DISORDER 3 0.0010
229 GROWTH RETARDATION 3 0.0010
230 DECREASED INTEREST 6 0.0010
231 HYPOAESTHESIA 151 0.0010
232 DIPLOPIA 26 0.0010
233 ANAL INCONTINENCE 9 0.0010
234 SKIN REACTION 14 0.0010
235 FOAMING AT MOUTH 2 0.0010
236 EAR HAEMORRHAGE 2 0.0010
237 GOITRE 4 0.0010
238 RECTAL CANCER 3 0.0010
239 PRODUCT TEMPERATURE EXCURSION ISSUE 5 0.0010
240 OLIGURIA 6 0.0010
241 IMPAIRED SELF-CARE 2 0.0010
242 INJECTION SITE HAEMORRHAGE 76 0.0010
243 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
244 ANAPHYLACTIC SHOCK 24 0.0009
245 EXOPHTHALMOS 2 0.0009
246 JAW FRACTURE 2 0.0009
247 ABORTION SPONTANEOUS 37 0.0009
248 IMMOBILE 4 0.0009
249 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
250 DYSGRAPHIA 6 0.0009
251 ENDOMETRIAL CANCER 2 0.0009
252 NEAR DEATH EXPERIENCE 3 0.0009
253 PARALYSIS 13 0.0009
254 OTITIS MEDIA 3 0.0009
255 SKIN MASS 6 0.0009
256 INFECTIOUS MONONUCLEOSIS 2 0.0009
257 BLOOD LOSS ANAEMIA 2 0.0009
258 URINE ABNORMALITY 4 0.0009
259 COGNITIVE DISORDER 41 0.0009
260 URINARY INCONTINENCE 26 0.0009
261 MICTURITION URGENCY 10 0.0009
262 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
263 HYPOPNOEA 3 0.0009
264 HYPOAESTHESIA ORAL 13 0.0009
265 APHASIA 26 0.0009
266 DRUG-INDUCED LIVER INJURY 27 0.0009
267 EAR PRURITUS 3 0.0009
268 HANGOVER 3 0.0009
269 INSURANCE ISSUE 13 0.0008
270 FEELING HOT 52 0.0008
271 INJECTION SITE RASH 26 0.0008
272 INGROWING NAIL 2 0.0008
273 HAEMORRHAGE SUBCUTANEOUS 3 0.0008
274 SARCOIDOSIS 4 0.0008
275 LIVE BIRTH 7 0.0008
276 CHILLS 98 0.0008
277 FACIAL BONES FRACTURE 3 0.0008
278 SPONDYLITIS 3 0.0008
279 FOETAL GROWTH RESTRICTION 5 0.0008
280 CUTANEOUS VASCULITIS 3 0.0008
281 UTERINE LEIOMYOMA 6 0.0008
282 SCAR 14 0.0008
283 SENSORY DISTURBANCE 13 0.0008
284 LIMB DISCOMFORT 25 0.0008
285 ANAPHYLACTIC REACTION 44 0.0008
286 LOSS OF CONTROL OF LEGS 3 0.0008
287 PURPURA 7 0.0008
288 BRAIN ABSCESS 2 0.0008
289 HOSTILITY 2 0.0008
290 APPENDICITIS PERFORATED 2 0.0008
291 ABDOMINAL INFECTION 2 0.0008
292 TEMPERATURE INTOLERANCE 8 0.0008
293 PANIC DISORDER 3 0.0008
294 HERNIA REPAIR 2 0.0008
295 HERPES SIMPLEX 5 0.0008
296 HEPATITIS TOXIC 2 0.0008
297 HYPOGAMMAGLOBULINAEMIA 5 0.0008
298 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
299 CYSTITIS 24 0.0008
300 CEREBRAL ATROPHY 3 0.0008
301 BLOOD POTASSIUM ABNORMAL 2 0.0007
302 DEVICE DEFECTIVE 13 0.0007
303 PREGNANCY 15 0.0007
304 SENSORY LOSS 6 0.0007
305 THROAT TIGHTNESS 20 0.0007
306 MUSCULAR WEAKNESS 84 0.0007
307 CHEST DISCOMFORT 75 0.0007
308 DEMYELINATION 3 0.0007
309 MATERNAL EXPOSURE BEFORE PREGNANCY 5 0.0007
310 INJECTION SITE EXTRAVASATION 9 0.0007
311 ANAPHYLACTOID REACTION 3 0.0007
312 HOSPITALISATION 112 0.0007
313 BALANCE DISORDER 63 0.0007
314 ENCEPHALITIS 5 0.0007
315 HEMIPLEGIA 6 0.0007
316 AUTOIMMUNE HEPATITIS 5 0.0007
317 MUSCLE FATIGUE 3 0.0007
318 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
319 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
320 MONOPLEGIA 3 0.0007
321 GAIT INABILITY 23 0.0007
322 BILIARY COLIC 2 0.0007
323 DYSPHEMIA 3 0.0007
324 BRADYKINESIA 4 0.0007
325 GAIT DISTURBANCE 129 0.0007
326 MALIGNANT MELANOMA 9 0.0007
327 INFUSION SITE REACTION 2 0.0007
328 MENINGITIS ASEPTIC 3 0.0007
329 MOBILITY DECREASED 48 0.0007
330 LUNG ADENOCARCINOMA 2 0.0007
331 KIDNEY INFECTION 13 0.0007
332 EYE INJURY 2 0.0007
333 BRAIN NEOPLASM 6 0.0007
334 DYSAESTHESIA 2 0.0007
335 ECTOPIC PREGNANCY 2 0.0006
336 CHRONIC MYELOID LEUKAEMIA 3 0.0006
337 PALPITATIONS 76 0.0006
338 DIASTOLIC DYSFUNCTION 2 0.0006
339 DEVICE ISSUE 58 0.0006
340 FOREIGN BODY IN THROAT 2 0.0006
341 CHRONIC LYMPHOCYTIC LEUKAEMIA 3 0.0006
342 GESTATIONAL DIABETES 3 0.0006
343 PRODUCT DOSE OMISSION 41 0.0006
344 PARAESTHESIA 98 0.0006
345 HEAD DISCOMFORT 11 0.0006
346 URTICARIA 104 0.0006
347 MUSCLE DISORDER 5 0.0006
348 REFUSAL OF TREATMENT BY PATIENT 4 0.0006
349 FEELING COLD 17 0.0006
350 HEPATOMEGALY 6 0.0006
351 ASPERGILLUS INFECTION 4 0.0006
352 INABILITY TO AFFORD MEDICATION 6 0.0006
353 URINARY TRACT INFECTION 103 0.0006
354 ADVERSE REACTION 8 0.0006
355 HYPOTONIA 6 0.0006
356 FALL 200 0.0006
357 THERAPY NON-RESPONDER 27 0.0006
358 WRONG PRODUCT ADMINISTERED 4 0.0006
359 ACCIDENT 7 0.0006
360 ORAL PAIN 13 0.0006
361 HYPERREFLEXIA 2 0.0006
362 SYRINGE ISSUE 10 0.0006
363 PRODUCT USE COMPLAINT 9 0.0006
364 COVID-19 100 0.0006
365 ERYTHEMA NODOSUM 2 0.0006
366 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
367 SPINAL OPERATION 7 0.0006
368 LYMPHOCYTE COUNT DECREASED 10 0.0006
369 NYSTAGMUS 3 0.0006
370 BREAST PAIN 6 0.0006
371 METASTASIS 4 0.0006
372 FACIAL PAIN 5 0.0006
373 JAUNDICE 15 0.0006
374 SKIN CANCER 12 0.0006
375 MUSCLE TIGHTNESS 9 0.0006
376 HYPERTHYROIDISM 8 0.0006
377 JAW DISORDER 3 0.0005
378 FAECALOMA 3 0.0005
379 NONSPECIFIC REACTION 3 0.0005
380 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 26 0.0005
381 PRODUCT DOSE OMISSION ISSUE 159 0.0005
382 SWELLING FACE 35 0.0005
383 LYMPHADENOPATHY 19 0.0005
384 INCORRECT DOSE ADMINISTERED BY DEVICE 14 0.0005
385 CHRONIC SINUSITIS 2 0.0005
386 MATERNAL EXPOSURE TIMING UNSPECIFIED 2 0.0005
387 DYSARTHRIA 20 0.0005
388 PREMATURE LABOUR 3 0.0005
389 MOUTH ULCERATION 11 0.0005
390 POST PROCEDURAL COMPLICATION 10 0.0005
391 LYMPHOMA 8 0.0005
392 ANKLE FRACTURE 8 0.0005
393 BLINDNESS 21 0.0005
394 CAESAREAN SECTION 6 0.0005
395 VASCULITIS 6 0.0005
396 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
397 CYANOSIS 8 0.0005
398 COVID-19 PNEUMONIA 6 0.0005
399 PLEURISY 3 0.0005
400 FOETAL EXPOSURE DURING PREGNANCY 41 0.0005
401 COORDINATION ABNORMAL 7 0.0005
402 NEPHROLITHIASIS 23 0.0005
403 THYROID CANCER 6 0.0005
404 MOVEMENT DISORDER 16 0.0005
405 UTERINE CANCER 4 0.0005
406 SPEECH DISORDER 26 0.0005
407 RHINITIS 4 0.0005
408 HYPERSENSITIVITY 92 0.0005
409 GALLBLADDER OPERATION 2 0.0005
410 SEIZURE 57 0.0005
411 HOMICIDAL IDEATION 2 0.0005
412 POST PROCEDURAL INFECTION 4 0.0005
413 TREMOR 81 0.0005
414 BURNING SENSATION 34 0.0005
415 GENERALISED TONIC-CLONIC SEIZURE 8 0.0005
416 SYNCOPE 48 0.0005
417 DYSSTASIA 14 0.0005
418 MUSCLE TWITCHING 11 0.0005
419 BRAIN OEDEMA 6 0.0005
420 KNEE ARTHROPLASTY 10 0.0005
421 HEAD INJURY 15 0.0005
422 FACIAL PARALYSIS 4 0.0005
423 INTERVERTEBRAL DISC DISORDER 2 0.0005
424 ADVERSE DRUG REACTION 42 0.0005
425 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
426 MEMORY IMPAIRMENT 64 0.0005
427 VISUAL IMPAIRMENT 57 0.0005
428 MELANOCYTIC NAEVUS 2 0.0005
429 CHEST PAIN 84 0.0005
430 CYTOMEGALOVIRUS INFECTION REACTIVATION 2 0.0005
431 NERVE INJURY 5 0.0004
432 SURGERY 26 0.0004
433 ULCER HAEMORRHAGE 3 0.0004
434 STATUS EPILEPTICUS 5 0.0004
435 INJURY ASSOCIATED WITH DEVICE 9 0.0004
436 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
437 PREMATURE DELIVERY 7 0.0004
438 PATHOGEN RESISTANCE 4 0.0004
439 EYE MOVEMENT DISORDER 3 0.0004
440 LOSS OF CONSCIOUSNESS 55 0.0004
441 FEELING OF DESPAIR 2 0.0004
442 SPINAL PAIN 5 0.0004
443 VERTIGO 26 0.0004
444 DYSPNOEA 241 0.0004
445 BLINDNESS UNILATERAL 6 0.0004
446 HAND FRACTURE 3 0.0004
447 THERMAL BURN 3 0.0004
448 FOOT FRACTURE 8 0.0004
449 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 4 0.0004
450 MACULAR DEGENERATION 5 0.0004
451 PARAESTHESIA ORAL 6 0.0004
452 PRODUCT PRESCRIBING ISSUE 9 0.0004
453 MENTAL IMPAIRMENT 10 0.0004
454 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
455 NEURALGIA 10 0.0004
456 CEREBRAL DISORDER 3 0.0004
457 FOOT OPERATION 2 0.0004
458 INFLUENZA LIKE ILLNESS 33 0.0004
459 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
460 ERYSIPELAS 2 0.0004
461 PEMPHIGOID 3 0.0004
462 DEVICE BREAKAGE 16 0.0004
463 ERYTHEMA 81 0.0004
464 HYPERTHERMIA 3 0.0004
465 DEVICE DIFFICULT TO USE 26 0.0004
466 EPILEPSY 12 0.0004
467 MOTOR DYSFUNCTION 4 0.0004
468 BOWEL MOVEMENT IRREGULARITY 3 0.0004
469 BACK PAIN 91 0.0004
470 CONGENITAL ANOMALY 3 0.0004
471 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
472 APHTHOUS ULCER 3 0.0004
473 APNOEA 3 0.0004
474 HYPERSOMNIA 11 0.0004
475 SARS-COV-2 TEST POSITIVE 5 0.0004
476 RENAL PAIN 4 0.0004
477 NEOPLASM MALIGNANT 25 0.0004
478 SWELLING 35 0.0004
479 CONTUSION 36 0.0004
480 HIP SURGERY 2 0.0004
481 DEVICE LEAKAGE 16 0.0004
482 DECUBITUS ULCER 3 0.0004
483 MUSCULOSKELETAL DISORDER 7 0.0004
484 LOWER LIMB FRACTURE 7 0.0004
485 DISEASE PROGRESSION 43 0.0004
486 HEART RATE INCREASED 36 0.0004
487 CEREBRAL HAEMORRHAGE 13 0.0004
488 DEAFNESS UNILATERAL 2 0.0004
489 CHOKING SENSATION 2 0.0004
490 HYPERKERATOSIS 2 0.0004
491 DIVERTICULITIS 10 0.0004
492 LIP SWELLING 12 0.0004
493 LEUKOPENIA 18 0.0004
494 ORAL HERPES 7 0.0004
495 ROAD TRAFFIC ACCIDENT 15 0.0004
496 ATRIAL SEPTAL DEFECT 3 0.0004
497 CARPAL TUNNEL SYNDROME 5 0.0004
498 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
499 SKIN INFECTION 4 0.0004
500 EYE INFECTION 4 0.0004
501 MITRAL VALVE INCOMPETENCE 4 0.0004
502 CIRCULATORY COLLAPSE 6 0.0004
503 GENERALISED ERYTHEMA 2 0.0004
504 HYPERTONIA 2 0.0003
505 CARDIAC OPERATION 3 0.0003
506 MUSCLE SPASMS 64 0.0003
507 CORONARY ARTERY BYPASS 2 0.0003
508 HERPES VIRUS INFECTION 2 0.0003
509 MUSCLE STRAIN 3 0.0003
510 MOUTH SWELLING 2 0.0003
511 ENTEROCOLITIS 2 0.0003
512 GASTROINTESTINAL DISORDER 31 0.0003
513 DIZZINESS 172 0.0003
514 INJECTION SITE HAEMATOMA 5 0.0003
515 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
516 HYPOKINESIA 5 0.0003
517 BODY TEMPERATURE INCREASED 7 0.0003
518 FATIGUE 266 0.0003
519 SEXUAL DYSFUNCTION 4 0.0003
520 GRIP STRENGTH DECREASED 3 0.0003
521 COLD SWEAT 6 0.0003
522 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
523 BLOOD IRON DECREASED 4 0.0003
524 DEPRESSION 76 0.0003
525 WRIST FRACTURE 4 0.0003
526 PREMATURE BABY 10 0.0003
527 HOT FLUSH 25 0.0003
528 HERPES ZOSTER 19 0.0003
529 PANIC ATTACK 12 0.0003
530 PAIN IN EXTREMITY 97 0.0003
531 FIBROMYALGIA 8 0.0003
532 DEVICE FAILURE 5 0.0003
533 RETCHING 7 0.0003
534 HIP ARTHROPLASTY 5 0.0003
535 SKIN DISCOLOURATION 15 0.0003
536 ENCEPHALOPATHY 8 0.0003
537 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
538 PRURITUS GENERALISED 7 0.0003
539 CYST 4 0.0003
540 HEPATIC STEATOSIS 6 0.0003
541 THINKING ABNORMAL 6 0.0003
542 ASTHENIA 120 0.0003
543 BRAIN FOG 5 0.0003
544 HYPERHIDROSIS 41 0.0003
545 PRODUCT DOSE OMISSION IN ERROR 9 0.0003
546 DRUG INEFFECTIVE 418 0.0003
547 ANGIOEDEMA 14 0.0003
548 PRODUCT PACKAGING ISSUE 3 0.0003
549 DISEASE RECURRENCE 15 0.0003
550 PNEUMOTHORAX 5 0.0003
551 ULCER 5 0.0003
552 INCREASED APPETITE 6 0.0003
553 ABSCESS 5 0.0003
554 DEVICE MALFUNCTION 22 0.0003
555 ENTERITIS 2 0.0003
556 AFFECT LABILITY 3 0.0003
557 ROTATOR CUFF SYNDROME 4 0.0003
558 DRUG RESISTANCE 8 0.0003
559 DISCOMFORT 19 0.0003
560 HIP FRACTURE 10 0.0003
561 PARKINSONISM 3 0.0003
562 CHOKING 6 0.0003
563 INFLAMMATORY BOWEL DISEASE 3 0.0003
564 VISION BLURRED 42 0.0003
565 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
566 SKIN IRRITATION 14 0.0003
567 THERAPY CHANGE 3 0.0003
568 BEDRIDDEN 4 0.0003
569 DISABILITY 6 0.0003
570 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
571 DEPRESSED MOOD 16 0.0003
572 UPPER LIMB FRACTURE 6 0.0003
573 FEELING ABNORMAL 72 0.0003
574 OVARIAN CYST 3 0.0003
575 URINARY RETENTION 10 0.0003
576 MENINGITIS 2 0.0003
577 BRAIN INJURY 3 0.0003
578 BREAST MASS 2 0.0003
579 VAGINAL DISCHARGE 3 0.0003
580 METASTASES TO LYMPH NODES 2 0.0003
581 TASTE DISORDER 6 0.0003
582 DRUG EXPOSURE DURING PREGNANCY 10 0.0003
583 ABNORMAL LOSS OF WEIGHT 2 0.0003
584 RIB FRACTURE 6 0.0003
585 SKIN LESION 8 0.0003
586 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 59 0.0003
587 LYMPHOEDEMA 2 0.0003
588 LARGE INTESTINE POLYP 2 0.0003
589 NERVOUS SYSTEM DISORDER 9 0.0003
590 PRESYNCOPE 7 0.0003
591 ORTHOSTATIC HYPOTENSION 5 0.0003
592 EXTRASYSTOLES 2 0.0003
593 WOUND 8 0.0003
594 MASS 4 0.0003
595 METASTASES TO LIVER 5 0.0003
596 HALLUCINATION, VISUAL 6 0.0003
597 INCONTINENCE 3 0.0003
598 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
599 EATING DISORDER 6 0.0003
600 ILLNESS 29 0.0003
601 CONFUSIONAL STATE 45 0.0003
602 IMPAIRED QUALITY OF LIFE 4 0.0003
603 ANXIETY 79 0.0003
604 AMNESIA 18 0.0003
605 CONDITION AGGRAVATED 84 0.0003
606 BIPOLAR DISORDER 3 0.0003
607 SKIN LACERATION 3 0.0003
608 RESTLESS LEGS SYNDROME 5 0.0003
609 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
610 MUSCULOSKELETAL STIFFNESS 24 0.0003
611 WOUND INFECTION 3 0.0003
612 EYE DISORDER 9 0.0003
613 EXPOSURE DURING PREGNANCY 17 0.0003
614 TOOTH FRACTURE 3 0.0003
615 DRUG EFFECT LESS THAN EXPECTED 4 0.0003
616 DRUG INTOLERANCE 26 0.0003
617 HEPATIC FUNCTION ABNORMAL 10 0.0003
618 OCULAR DISCOMFORT 3 0.0003
619 HYDRONEPHROSIS 2 0.0003
620 INTESTINAL OBSTRUCTION 10 0.0003
621 PRODUCT AVAILABILITY ISSUE 6 0.0003
622 BLOOD URINE PRESENT 5 0.0003
623 MIGRAINE 25 0.0003
624 NEOPLASM 3 0.0003
625 PHARYNGEAL OEDEMA 4 0.0003
626 ATRIOVENTRICULAR BLOCK 2 0.0003
627 LIMB INJURY 7 0.0003
628 DELUSION 4 0.0003
629 BASAL CELL CARCINOMA 4 0.0003
630 SWOLLEN TONGUE 8 0.0003
631 MULTIPLE ALLERGIES 2 0.0003
632 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
633 SINUS DISORDER 5 0.0003
634 BLOOD ALBUMIN DECREASED 2 0.0003
635 LOW BIRTH WEIGHT BABY 2 0.0003
636 PYREXIA 86 0.0002
637 FRUSTRATION TOLERANCE DECREASED 2 0.0002
638 BREAST CANCER 23 0.0002
639 COLITIS ULCERATIVE 11 0.0002
640 INTENTIONAL DOSE OMISSION 7 0.0002
641 HYPERAESTHESIA 2 0.0002
642 LETHARGY 14 0.0002
643 ESCHERICHIA INFECTION 2 0.0002
644 INFLUENZA 27 0.0002
645 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
646 ILEUS 3 0.0002
647 FUNGAL INFECTION 8 0.0002
648 EOSINOPHIL COUNT INCREASED 2 0.0002
649 POLLAKIURIA 10 0.0002
650 DERMATITIS ALLERGIC 3 0.0002
651 TREATMENT NONCOMPLIANCE 13 0.0002
652 COLITIS 9 0.0002
653 FACE OEDEMA 4 0.0002
654 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 8 0.0002
655 MUSCLE ATROPHY 3 0.0002
656 INFECTION 34 0.0002
657 MUSCULOSKELETAL DISCOMFORT 4 0.0002
658 BLOOD MAGNESIUM DECREASED 2 0.0002
659 NEUROPATHY PERIPHERAL 22 0.0002
660 CARDIAC MURMUR 2 0.0002
661 HYSTERECTOMY 2 0.0002
662 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
663 PRODUCT DISPENSING ERROR 5 0.0002
664 ORAL CANDIDIASIS 3 0.0002
665 IMMUNE SYSTEM DISORDER 3 0.0002
666 ANKYLOSING SPONDYLITIS 3 0.0002
667 ABDOMINAL DISCOMFORT 38 0.0002
668 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
669 GENERAL PHYSICAL HEALTH DETERIORATION 26 0.0002
670 HEPATOTOXICITY 5 0.0002
671 THROMBOSIS 18 0.0002
672 INCORRECT DOSE ADMINISTERED 51 0.0002
673 PAIN 137 0.0002
674 HEADACHE 139 0.0002
675 GASTROENTERITIS VIRAL 4 0.0002
676 LEUKOCYTOSIS 4 0.0002
677 DRUG INTERACTION 35 0.0002
678 MOOD SWINGS 7 0.0002
679 ACUTE HEPATIC FAILURE 3 0.0002
680 DEVICE DELIVERY SYSTEM ISSUE 6 0.0002
681 PERIPHERAL COLDNESS 3 0.0002
682 CELLULITIS 11 0.0002
683 DYSURIA 8 0.0002
684 PRURITUS 83 0.0002
685 DYSGEUSIA 16 0.0002
686 EYE SWELLING 8 0.0002
687 ERYTHEMA MULTIFORME 2 0.0002
688 BACTERIAL INFECTION 4 0.0002
689 APPENDICITIS 2 0.0002
690 DIARRHOEA HAEMORRHAGIC 2 0.0002
691 IMPAIRED HEALING 7 0.0002
692 STAPHYLOCOCCAL INFECTION 7 0.0002
693 LEUKAEMIA 2 0.0002
694 VISUAL ACUITY REDUCED 7 0.0002
695 DYSPHAGIA 20 0.0002
696 PROTEINURIA 4 0.0002
697 SKIN DISORDER 7 0.0002
698 MYELODYSPLASTIC SYNDROME 3 0.0002
699 LOCALISED INFECTION 5 0.0002
700 ASCITES 6 0.0002
701 NAUSEA 161 0.0002
702 KNEE OPERATION 2 0.0002
703 LABORATORY TEST ABNORMAL 6 0.0002
704 TACHYCARDIA 18 0.0002
705 HOSPICE CARE 2 0.0002
706 LIGAMENT SPRAIN 2 0.0002
707 HAEMATOCRIT DECREASED 4 0.0002
708 BLOOD PRESSURE ABNORMAL 4 0.0002
709 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
710 HEART RATE DECREASED 7 0.0002
711 PRODUCT ADMINISTRATION ERROR 4 0.0002
712 HYPOTHERMIA 2 0.0002
713 NECK PAIN 11 0.0002
714 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
715 TINNITUS 9 0.0002
716 RASH 85 0.0002
717 EAR DISCOMFORT 2 0.0002
718 INFLAMMATION 10 0.0002
719 FEMUR FRACTURE 6 0.0002
720 PRODUCT QUALITY ISSUE 26 0.0002
721 FULL BLOOD COUNT ABNORMAL 2 0.0002
722 CEREBROVASCULAR ACCIDENT 32 0.0002
723 SCIATICA 3 0.0002
724 DYSPHONIA 11 0.0002
725 EAR INFECTION 5 0.0002
726 HYPOTHYROIDISM 6 0.0002
727 WEIGHT INCREASED 42 0.0002
728 JOINT INJURY 4 0.0002
729 BREAST CANCER METASTATIC 2 0.0002
730 SUICIDAL IDEATION 17 0.0002
731 DECREASED ACTIVITY 2 0.0002
732 BLOOD BILIRUBIN INCREASED 5 0.0002
733 MENSTRUATION DELAYED 2 0.0002
734 RASH PRURITIC 10 0.0002
735 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
736 PRODUCT STORAGE ERROR 16 0.0002
737 MANIA 3 0.0002
738 GASTROINTESTINAL PAIN 2 0.0002
739 DENTAL CARIES 2 0.0002
740 VOMITING 85 0.0002
741 FOOT DEFORMITY 2 0.0002
742 VIRAL INFECTION 6 0.0002
743 ARTHROPATHY 10 0.0002
744 HYPERTENSIVE CRISIS 2 0.0002
745 DEMENTIA 5 0.0002
746 THROAT IRRITATION 8 0.0002
747 ARTHRITIS 14 0.0002
748 OXYGEN SATURATION DECREASED 10 0.0002
749 MYOCARDIAL ISCHAEMIA 2 0.0002
750 GASTRIC DISORDER 6 0.0002
751 PARANOIA 3 0.0002
752 SHOCK 4 0.0002
753 ADVERSE EVENT 16 0.0002
754 NASOPHARYNGITIS 32 0.0002
755 MALAISE 76 0.0002
756 OROPHARYNGEAL PAIN 16 0.0002
757 DYSKINESIA 7 0.0002
758 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8 0.0002
759 AMENORRHOEA 3 0.0002
760 SEPSIS 19 0.0002
761 PSYCHOTIC DISORDER 5 0.0002
762 PRODUCT PRESCRIBING ERROR 4 0.0002
763 HYPERLIPIDAEMIA 2 0.0002
764 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 30 0.0002
765 INFUSION RELATED REACTION 11 0.0002
766 HEPATIC FAILURE 5 0.0002
767 OSTEOMYELITIS 3 0.0002
768 OSTEOARTHRITIS 7 0.0002
769 MYALGIA 28 0.0002
770 BONE DISORDER 3 0.0002
771 SOMNOLENCE 33 0.0002
772 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 3 0.0002
773 HEPATIC ENZYME INCREASED 11 0.0002
774 CARDIAC DISORDER 15 0.0002
775 ABDOMINAL PAIN UPPER 33 0.0002
776 PNEUMONIA ASPIRATION 4 0.0002
777 EYE PAIN 9 0.0002
778 ARTHRALGIA 66 0.0002
779 PNEUMONIA 51 0.0002
780 TREATMENT FAILURE 13 0.0002
781 PULMONARY FIBROSIS 3 0.0002
782 HEPATITIS 4 0.0002
783 CHOLESTASIS 3 0.0002
784 THERAPEUTIC RESPONSE UNEXPECTED 7 0.0002
785 SLEEP DISORDER 11 0.0002
786 HYPERTENSION 33 0.0002
787 GLAUCOMA 3 0.0002
788 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
789 UNRESPONSIVE TO STIMULI 4 0.0002
790 HAEMATOMA 4 0.0002
791 EAR PAIN 3 0.0002
792 WEIGHT DECREASED 43 0.0002
793 NERVOUSNESS 8 0.0002
794 MUSCULOSKELETAL PAIN 8 0.0002
795 ABDOMINAL PAIN 35 0.0002
796 EYE HAEMORRHAGE 2 0.0001
797 SPINAL FRACTURE 3 0.0001
798 DISTURBANCE IN ATTENTION 8 0.0001
799 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
800 ILL-DEFINED DISORDER 9 0.0001
801 ANGER 5 0.0001
802 PSORIATIC ARTHROPATHY 6 0.0001
803 ALOPECIA 29 0.0001
804 PALLOR 4 0.0001
805 IMPAIRED GASTRIC EMPTYING 2 0.0001
806 RESPIRATORY ARREST 4 0.0001
807 RESPIRATORY DISTRESS 4 0.0001
808 MENTAL STATUS CHANGES 4 0.0001
809 BLOOD PRESSURE INCREASED 22 0.0001
810 ABDOMINAL DISTENSION 15 0.0001
811 APHONIA 2 0.0001
812 BLOOD TEST ABNORMAL 2 0.0001
813 PAIN IN JAW 4 0.0001
814 NEUTROPENIA 19 0.0001
815 CARDIOGENIC SHOCK 2 0.0001
816 HYPOACUSIS 6 0.0001
817 INSOMNIA 37 0.0001
818 FAECES DISCOLOURED 3 0.0001
819 INTENTIONAL PRODUCT MISUSE 12 0.0001
820 GASTROENTERITIS 2 0.0001
821 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
822 TOOTH DISORDER 3 0.0001
823 IMMUNODEFICIENCY 2 0.0001
824 HAEMORRHAGE 14 0.0001
825 DEATH 115 0.0001
826 BLOOD POTASSIUM DECREASED 4 0.0001
827 CONSTIPATION 29 0.0001
828 CHROMATURIA 3 0.0001
829 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
830 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
831 PLEURAL EFFUSION 8 0.0001
832 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
833 PERIPHERAL SWELLING 20 0.0001
834 RENAL DISORDER 6 0.0001
835 MENINGIOMA 2 0.0001
836 PULMONARY EMBOLISM 12 0.0001
837 HYPONATRAEMIA 7 0.0001
838 BACK DISORDER 2 0.0001
839 CEREBRAL INFARCTION 3 0.0001
840 CHOLELITHIASIS 4 0.0001
841 METASTASES TO BONE 2 0.0001
842 OSTEONECROSIS 4 0.0001
843 BRONCHITIS 9 0.0001
844 MYOCARDIAL INFARCTION 21 0.0001
845 CYTOMEGALOVIRUS INFECTION 2 0.0001
846 UNEVALUABLE EVENT 9 0.0001
847 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
848 HAEMATEMESIS 3 0.0001
849 DIABETES MELLITUS 9 0.0001
850 SINUSITIS 12 0.0001
851 HAEMATURIA 4 0.0001
852 SKIN ULCER 3 0.0001
853 RESPIRATORY TRACT INFECTION 3 0.0001
854 OEDEMA PERIPHERAL 14 0.0001
855 DEAFNESS 3 0.0001
856 SEDATION 3 0.0001
857 RASH MACULAR 4 0.0001
858 JOINT STIFFNESS 3 0.0001
859 ANHEDONIA 3 0.0001
860 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
861 PANCREATITIS 6 0.0001
862 DEHYDRATION 15 0.0001
863 DRY MOUTH 9 0.0001
864 OFF LABEL USE 97 0.0001
865 COUGH 31 0.0001
866 HAEMATOCHEZIA 6 0.0001
867 CONJUNCTIVITIS 2 0.0001
868 DIARRHOEA 69 0.0001
869 HEPATIC CIRRHOSIS 2 0.0001
870 OCULAR HYPERAEMIA 5 0.0001
871 GASTRIC ULCER 2 0.0001
872 FEELING JITTERY 2 0.0001
873 RED BLOOD CELL COUNT DECREASED 3 0.0001
874 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
875 DRUG DOSE OMISSION BY DEVICE 8 0.0001
876 LUNG DISORDER 5 0.0001
877 DISORIENTATION 4 0.0001
878 DRY EYE 5 0.0001
879 INJURY 7 0.0001
880 LACRIMATION INCREASED 3 0.0001
881 THERAPEUTIC RESPONSE DECREASED 6 0.0001
882 FEEDING DISORDER 2 0.0001
883 ALANINE AMINOTRANSFERASE INCREASED 6 0.0001
884 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
885 RESPIRATORY FAILURE 7 0.0001
886 BRADYCARDIA 5 0.0001
887 EPISTAXIS 7 0.0001
888 IRRITABLE BOWEL SYNDROME 2 0.0001
889 LIVER FUNCTION TEST INCREASED 2 0.0001
890 NIGHT SWEATS 3 0.0001
891 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
892 VAGINAL HAEMORRHAGE 4 0.0001
893 RENAL FAILURE 12 0.0001
894 BLOOD PRESSURE DECREASED 6 0.0001
895 LIVER DISORDER 4 0.0001
896 GLOSSODYNIA 2 0.0001
897 PULMONARY OEDEMA 4 0.0001
898 EYE PRURITUS 3 0.0001
899 HEART RATE IRREGULAR 2 0.0001
900 DEVICE USE ERROR 3 0.0001
901 DECREASED APPETITE 20 0.0001
902 HYPOXIA 3 0.0001
903 HYPOTENSION 17 0.0001
904 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
905 WHEEZING 5 0.0001
906 COMA 4 0.0001
907 RENAL CANCER 4 0.0001
908 BLOOD PRESSURE FLUCTUATION 2 0.0001
909 BLOOD GLUCOSE DECREASED 4 0.0001
910 IRRITABILITY 5 0.0001
911 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
912 UNDERDOSE 6 0.0001
913 LIVER INJURY 2 0.0001
914 DYSPEPSIA 8 0.0001
915 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
916 AGGRESSION 4 0.0001
917 PRODUCT USE ISSUE 15 0.0001
918 ASTHMA 9 0.0001
919 ABDOMINAL PAIN LOWER 2 0.0001
920 CHRONIC KIDNEY DISEASE 6 0.0001
921 CARDIOVASCULAR DISORDER 2 0.0001
922 EXPOSURE VIA SKIN CONTACT 2 0.0001
923 ECZEMA 4 0.0001
924 GASTRITIS 2 0.0001
925 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
926 CARDIAC FAILURE CONGESTIVE 6 0.0001
927 MENSTRUATION IRREGULAR 2 0.0001
928 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
929 FEAR 2 0.0001
930 FREQUENT BOWEL MOVEMENTS 2 0.0001
931 OSTEOPOROSIS 3 0.0001
932 MEDICATION ERROR 4 0.0001
933 ATRIAL FIBRILLATION 7 0.0001
934 BLISTER 4 0.0001
935 CONVULSION 4 0.0001
936 ANGINA PECTORIS 2 0.0001
937 SEPTIC SHOCK 3 0.0001
938 MENTAL DISORDER 3 0.0001
939 PSORIASIS 9 0.0001
940 LIVER FUNCTION TEST ABNORMAL 2 0.0001
941 HALLUCINATION 5 0.0001
942 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
943 CORONARY ARTERY DISEASE 2 0.0001
944 STOMATITIS 4 0.0001
945 HYPOKALAEMIA 3 0.0001
946 EMOTIONAL DISORDER 2 0.0001
947 CARDIAC FAILURE 5 0.0001
948 HYPOGLYCAEMIA 3 0.0001
949 CARDIAC ARREST 5 0.0001
950 FEBRILE NEUTROPENIA 4 0.0001
951 EXPIRED PRODUCT ADMINISTERED 2 0.0001
952 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
953 SKIN EXFOLIATION 5 0.0001
954 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
955 CRYING 2 0.0001
956 C-REACTIVE PROTEIN INCREASED 2 0.0001
957 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
958 AGITATION 4 0.0001
959 DRUG DOSE OMISSION 9 0.0001
960 EYE IRRITATION 3 0.0001
961 BONE PAIN 3 0.0001
962 NASAL CONGESTION 3 0.0001
963 ABNORMAL BEHAVIOUR 2 0.0001
964 CATARACT 3 0.0001
965 JOINT SWELLING 6 0.0000
966 NO ADVERSE EVENT 9 0.0000
967 HAEMOGLOBIN DECREASED 5 0.0000
968 CARDIO-RESPIRATORY ARREST 2 0.0000
969 RENAL IMPAIRMENT 4 0.0000
970 ANAEMIA 9 0.0000
971 RHINORRHOEA 3 0.0000
972 DEEP VEIN THROMBOSIS 3 0.0000
973 THROMBOCYTOPENIA 5 0.0000
974 BLOOD CHOLESTEROL INCREASED 2 0.0000
975 ARRHYTHMIA 2 0.0000
976 TOXICITY TO VARIOUS AGENTS 7 0.0000
977 EMOTIONAL DISTRESS 5 0.0000
978 ACNE 3 0.0000
979 FLUID RETENTION 2 0.0000
980 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
981 DRY SKIN 5 0.0000
982 PROSTATE CANCER 3 0.0000
983 DRUG EFFECT DECREASED 2 0.0000
984 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
985 COMPLETED SUICIDE 3 0.0000
986 BLOOD CREATININE INCREASED 2 0.0000
987 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
988 BLOOD GLUCOSE INCREASED 5 0.0000
989 DRUG ABUSE 2 0.0000
990 OVERDOSE 5 0.0000
991 DRUG WITHDRAWAL SYNDROME 2 0.0000
992 DRUG DEPENDENCE 2 0.0000